Rhythm Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity. 

CEO
David P. Meeker
CEODavid P. Meeker
Employees
140
Employees140
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2008
Founded2008
Employees
140
Employees140

RYTM Key Statistics

Market cap
1.54B
Market cap1.54B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
601.32K
Average volume601.32K
High today
$27.93
High today$27.93
Low today
$26.61
Low today$26.61
Open price
$26.68
Open price$26.68
Volume
681.48K
Volume681.48K
52 Week high
$34.99
52 Week high$34.99
52 Week low
$3.04
52 Week low$3.04

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

RYTM Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 1, Pre-Market
ActualExpected Mar 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.